Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10292-60-1

Post Buying Request

10292-60-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10292-60-1 Usage

Description

Phenol, 2-cyclopropyl-, is an organic compound characterized by the presence of a cyclopropyl group attached to a phenol molecule. This unique structure endows it with specific chemical and biological properties, making it a versatile compound in various applications.

Uses

Used in Pharmaceutical Industry:
Phenol, 2-cyclopropyl-, is used as a reagent for the preparation of imidazolines, which exhibit significant adrenergic α2C-Agonism/α2A-Antagonism. These imidazolines are important in the development of medications targeting the adrenergic system, which plays a crucial role in the regulation of various physiological processes, including blood pressure, heart rate, and stress response.
Used in Chemical Synthesis:
Phenol, 2-cyclopropyl-, is also utilized as an intermediate in the preparation of Cirazoline Hydrochloride (C497400), a potent α-1 adrenergic receptor agonist and an even more potent α-2 receptor antagonist. Phenol, 2-cyclopropylhas potential applications in the treatment of various medical conditions, such as hypotension and other cardiovascular disorders, where modulation of adrenergic receptors is necessary.

Check Digit Verification of cas no

The CAS Registry Mumber 10292-60-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,9 and 2 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 10292-60:
(7*1)+(6*0)+(5*2)+(4*9)+(3*2)+(2*6)+(1*0)=71
71 % 10 = 1
So 10292-60-1 is a valid CAS Registry Number.

10292-60-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Cyclopropylphenol

1.2 Other means of identification

Product number -
Other names ortho-cyclopropylphenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10292-60-1 SDS

10292-60-1Relevant articles and documents

Novel photohydration of non-conjugated aryl/olefin bichromophores within cyclodextrin cavities

Benali,Jimenez,Miranda,Tormos

, p. 2328 - 2329 (2001)

Cyclodextrin media are used to achieve photochemical water addition to isolated, acyclic double bonds via intramolecular interaction with excited arenes.

Isomerization of 2-(2-propenoxy)phenyllithium: Tandem anionic cyclization-γ-elimination

Bailey, William F.,Punzalan, Eric R.

, p. 5435 - 5436 (1996)

2-(2-Propenoxy)phenyllithium (1), which may be prepared from the corresponding iodide by low-temperature lithium-iodine exchange, rearranges on warming in the presence of TMEDA via 5-exo cyclization to (2,3-dihydrobenzofuranyl)methyllithium (2) followed by γ-elimination to give variable amounts of the lithium salt of 2-(cyclopropyl)phenol (3).

Diastereo- and enantioselective carbolithiation of allyl o-lithioaryl ethers. New chiral cyclopropane derivatives

Barluenga, Jose,Fananas, Francisco J.,Sanz, Roberto,Marcos, Cesar

, p. 2225 - 2228 (2002)

(matrix presented) Different allyl 2-lithioaryl ethers undergo a tandem carbolithiation/γ-elimination in Et2OH-MEDA affording o-cyclopropyl phenol or naphthol derivatives in a diastereoselective manner. The use of (-)-sparteine as a chiral liga

5H-PYRROLO[3,4-£>]PYRAZIN-7-AMINE DERIVATIVES INHIBITORS OF BETA-SECRETASE

-

Page/Page column 43-44, (2011/02/24)

The present invention relates to novel compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Downs syndrome, β- amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI ("mild cognitive impairment"), Alzheimer Disease, memory loss, attention deficit symptoms associated with Alzheimer disease, neurodegeneration associated with diseases such as Alzheimer disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.

NEW COMPOUNDS 574

-

Page/Page column 27, (2010/06/13)

The present invention relates to novel compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Downs syndrome,

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10292-60-1